
Jennifer Castriotta
Examiner (ID: 2648, Phone: (571)270-5279 , Office: P/3781 )
| Most Active Art Unit | 3733 |
| Art Unit(s) | 3781, 3733 |
| Total Applications | 769 |
| Issued Applications | 457 |
| Pending Applications | 68 |
| Abandoned Applications | 260 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10281638
[patent_doc_number] => 20150166635
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'GPR88 MINI-PROMOTERS'
[patent_app_type] => utility
[patent_app_number] => 14/487982
[patent_app_country] => US
[patent_app_date] => 2014-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9385
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14487982
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/487982 | GPR88 MINI-PROMOTERS | Sep 15, 2014 | Abandoned |
Array
(
[id] => 16923446
[patent_doc_number] => 11044896
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use
[patent_app_type] => utility
[patent_app_number] => 15/021026
[patent_app_country] => US
[patent_app_date] => 2014-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 10
[patent_no_of_words] => 10216
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021026
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/021026 | T cell receptors that are specific to a fluorescent protein, transgenic animals and methods of their making, isolated T cells, and methods of use | Sep 11, 2014 | Issued |
Array
(
[id] => 9917213
[patent_doc_number] => 20150072418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'HCV GENOTYPE 4D REPLICONS'
[patent_app_type] => utility
[patent_app_number] => 14/459913
[patent_app_country] => US
[patent_app_date] => 2014-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9197
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14459913
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/459913 | HCV GENOTYPE 4D REPLICONS | Aug 13, 2014 | Abandoned |
Array
(
[id] => 16607160
[patent_doc_number] => 10908161
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-02
[patent_title] => Corneal endothelial cell marker
[patent_app_type] => utility
[patent_app_number] => 14/908036
[patent_app_country] => US
[patent_app_date] => 2014-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 28304
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908036
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/908036 | Corneal endothelial cell marker | Jul 27, 2014 | Issued |
Array
(
[id] => 15606527
[patent_doc_number] => 10584313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-10
[patent_title] => Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere
[patent_app_type] => utility
[patent_app_number] => 14/338596
[patent_app_country] => US
[patent_app_date] => 2014-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30480
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14338596
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/338596 | Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere | Jul 22, 2014 | Issued |
Array
(
[id] => 13635309
[patent_doc_number] => 09844605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-19
[patent_title] => Transgenic
[patent_app_type] => utility
[patent_app_number] => 14/335413
[patent_app_country] => US
[patent_app_date] => 2014-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 98
[patent_no_of_words] => 19159
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14335413
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/335413 | Transgenic | Jul 17, 2014 | Issued |
Array
(
[id] => 11479373
[patent_doc_number] => 09585894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-07
[patent_title] => 'Compositions comprising exemestane and novel methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/333914
[patent_app_country] => US
[patent_app_date] => 2014-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 18
[patent_no_of_words] => 13709
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14333914
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/333914 | Compositions comprising exemestane and novel methods of use | Jul 16, 2014 | Issued |
Array
(
[id] => 11075965
[patent_doc_number] => 20160272929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-22
[patent_title] => 'METHOD FOR CULTURING PLURIPOTENT STEM CELLS, AND FACILITY THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 15/035879
[patent_app_country] => US
[patent_app_date] => 2014-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7659
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035879
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035879 | Facility for culturing pluripotent stem cells | Jul 10, 2014 | Issued |
Array
(
[id] => 14665507
[patent_doc_number] => 10370644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Method for making human pluripotent suspension cultures and cells derived therefrom
[patent_app_type] => utility
[patent_app_number] => 14/307100
[patent_app_country] => US
[patent_app_date] => 2014-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 151
[patent_figures_cnt] => 137
[patent_no_of_words] => 36084
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14307100
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/307100 | Method for making human pluripotent suspension cultures and cells derived therefrom | Jun 16, 2014 | Issued |
Array
(
[id] => 11464063
[patent_doc_number] => 09580683
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells'
[patent_app_type] => utility
[patent_app_number] => 14/302384
[patent_app_country] => US
[patent_app_date] => 2014-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6902
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14302384
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/302384 | ES cell cytoplasm or ooplasm transfer to rejuventate recipient cells | Jun 10, 2014 | Issued |
Array
(
[id] => 11403012
[patent_doc_number] => 20170023550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL'
[patent_app_type] => utility
[patent_app_number] => 15/301641
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18781
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301641
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301641 | ENGINEERED THREE-DIMENSIONAL BREAST TISSUE, ADIPOSE TISSUE, AND TUMOR DISEASE MODEL | Jun 5, 2014 | Abandoned |
Array
(
[id] => 11670349
[patent_doc_number] => 20170159070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'TRANSPOSON FOR GENOME MANIPULATION'
[patent_app_type] => utility
[patent_app_number] => 15/316508
[patent_app_country] => US
[patent_app_date] => 2014-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12123
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15316508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/316508 | TRANSPOSON FOR GENOME MANIPULATION | Jun 5, 2014 | Abandoned |
Array
(
[id] => 9757259
[patent_doc_number] => 20140287960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'ENGINEERED LIVER TISSUES, ARRAYS THEREOF, AND METHODS OF MAKING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/295226
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27878
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14295226
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/295226 | Engineered liver tissues, arrays thereof, and methods of making the same | Jun 2, 2014 | Issued |
Array
(
[id] => 11736065
[patent_doc_number] => 09700636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-11
[patent_title] => 'Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT)'
[patent_app_type] => utility
[patent_app_number] => 14/294674
[patent_app_country] => US
[patent_app_date] => 2014-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4562
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14294674
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/294674 | Method of gene transfer for the treatment of recessive catecholaminergic polymorphic ventricular tachycardia (CPVT) | Jun 2, 2014 | Issued |
Array
(
[id] => 15817015
[patent_doc_number] => 10633674
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Mammalian gene modification method using electroporation
[patent_app_type] => utility
[patent_app_number] => 15/025365
[patent_app_country] => US
[patent_app_date] => 2014-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 18915
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15025365
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/025365 | Mammalian gene modification method using electroporation | May 26, 2014 | Issued |
Array
(
[id] => 10800631
[patent_doc_number] => 20160146788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-26
[patent_title] => 'METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC.'
[patent_app_type] => utility
[patent_app_number] => 14/893470
[patent_app_country] => US
[patent_app_date] => 2014-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 17305
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14893470
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/893470 | METHOD FOR SCREENING DRUGS FOR TREATING/PREVENTING MYELODYSPLASTIC SYNDROME, ETC. | May 22, 2014 | Abandoned |
Array
(
[id] => 10743270
[patent_doc_number] => 20160089421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/892474
[patent_app_country] => US
[patent_app_date] => 2014-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14211
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14892474
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/892474 | STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR | May 20, 2014 | Abandoned |
Array
(
[id] => 9740643
[patent_doc_number] => 20140276362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'APPARATUS AND METHOD FOR TISSUE REJUVENATION'
[patent_app_type] => utility
[patent_app_number] => 14/278460
[patent_app_country] => US
[patent_app_date] => 2014-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19504
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14278460
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/278460 | APPARATUS AND METHOD FOR TISSUE REJUVENATION | May 14, 2014 | Abandoned |
Array
(
[id] => 10743246
[patent_doc_number] => 20160089397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-31
[patent_title] => 'CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES'
[patent_app_type] => utility
[patent_app_number] => 14/891064
[patent_app_country] => US
[patent_app_date] => 2014-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 16895
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14891064
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/891064 | CORRELATES OF EFFICACY RELATING TO TUMOR VACCINES | May 14, 2014 | Abandoned |
Array
(
[id] => 10919230
[patent_doc_number] => 20140322249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'DNA VACCINES AGAINST TUMOR GROWTH AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/269998
[patent_app_country] => US
[patent_app_date] => 2014-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 45
[patent_no_of_words] => 16785
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14269998
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/269998 | DNA vaccines against tumor growth and methods of use thereof | May 4, 2014 | Issued |